Acer Therapeutics Inc (NASDAQ:ACER)

18.16
Delayed Data
As of Feb 22
 -0.4825 / -2.59%
Today’s Change
5.70
Today|||52-Week Range
22.63
+31.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-1.7M-926.3K-678.2K-8.4M
 
 
 
 
 
Depreciation47.8K0.000.002.7K
 
 
 
Total Other Cash Flow1.1M48.3K48.3K285.9K
 
 
 
 
 
Funds From Operations-537.4K-878.0K-629.9K-8.1M
 
 
 
 
 
Funds From/For Other Operating Expenses1.8M143.2K303.1K-152.7K
 
 
 
 
 
Net Cash Flow - Operating Activities-2.3M-1.0M-933.0K-7.9M
 
 
 
 
 
 
InvestingFixed Asset Disposal--50.0K0.00980.1K
 
 
 
Net Cash Flow Investing0.0050.0K0.00977.6K
 
 
 
 
FinancingShort Term Borrowings-38.4K-64.8K-65.3K5.6M
 
 
 
 
 
Long Term Borrowings-3.1K0.000.00-68.5K
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.00413.7K0.009.6M
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-41.4K348.9K-65.3K15.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-2.4M-622.3K-998.3K8.2M